Key Insights

Highlights

Success Rate

75% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

4.5%

1 terminated out of 22 trials

Success Rate

75.0%

-11.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

75% success

Data Visualizations

Phase Distribution

20Total
Not Applicable (6)
Early P 1 (2)
P 1 (7)
P 2 (5)

Trial Status

Recruiting14
Completed3
Withdrawn2
Active Not Recruiting2
Terminated1

Trial Success Rate

75.0%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT06667726Phase 2RecruitingPrimary

An Investigational Scan (18F-DOPA PET/CT) for Improving the Clinical Management of Brain Tumors

NCT04475640Not ApplicableRecruiting

Cancer Genetic Testing in Ethnic Populations

NCT04510051Phase 1RecruitingPrimary

CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children

NCT06132685Phase 2Recruiting

Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial

NCT03510208Phase 1RecruitingPrimary

Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

NCT04459273Phase 1Active Not Recruiting

Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers

NCT06650163Phase 1Recruiting

Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors

NCT07339085Not ApplicableRecruitingPrimary

Advanced Magnetic Resonance Imaging for the Identification of Recurrent Brain Tumors and Radiation Necrosis

NCT06788886Not ApplicableRecruitingPrimary

Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases

NCT07174661Not ApplicableRecruiting

Educational Tools for the Improvement of Early Advance Care Planning in Adolescents and Young Adults With Advanced Solid Tumors and High-Grade Brain Tumors

NCT03823144Not ApplicableRecruiting

Intravital Microscopy in Human Solid Tumors

NCT07259304Recruiting

Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors

NCT06377696Phase 2RecruitingPrimary

Remote Cognitive Assessment and Wearable Device While Assessing the Impact of Metformin in Patients With History of Cranial Radiation Therapy

NCT07118176Phase 1Recruiting

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

NCT06494046Withdrawn

Defining Musical Toxicity and Its Effect on Patient Well-being

NCT03649880Phase 2RecruitingPrimary

Feasibility of FMISO in Brain Tumors

NCT04521946Phase 1Withdrawn

Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer

NCT05139043Phase 2Active Not RecruitingPrimary

Low Dose Versus Standard Dose Dexamethasone for Reduction of Swelling in Patients with Primary or Metastatic Brain Tumors

NCT04067960Early Phase 1Completed

Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer

NCT04752267Early Phase 1Completed

18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases

Scroll to load more

Research Network

Activity Timeline